Eugene Y Rhee, MD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Promescent Lidocaine Spray · Urology / Sexual Health
Lidocaine spray topically anesthetizes nerve endings in penile tissue to reduce sensory stimulation and delay ejaculation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Eugene Y Rhee, MD portfolio CI brief
Eugene Y Rhee, MD pipeline updates RSS

Frequently asked questions about Eugene Y Rhee, MD

What is Eugene Y Rhee, MD's pipeline?

Eugene Y Rhee, MD has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Promescent Lidocaine Spray.

Sector hub: All tracked pharma companies